123 related articles for article (PubMed ID: 3111877)
21. Electron microscopic evidence of persistent chlamydial infection following treatment.
Bragina EY; Gomberg MA; Dmitriev GA
J Eur Acad Dermatol Venereol; 2001 Sep; 15(5):405-9. PubMed ID: 11763379
[TBL] [Abstract][Full Text] [Related]
22. Chlamydia pneumoniae expresses genes required for DNA replication but not cytokinesis during persistent infection of HEp-2 cells.
Byrne GI; Ouellette SP; Wang Z; Rao JP; Lu L; Beatty WL; Hudson AP
Infect Immun; 2001 Sep; 69(9):5423-9. PubMed ID: 11500413
[TBL] [Abstract][Full Text] [Related]
23. Effect of Ureaplasma parvum co-incubation on Chlamydia trachomatis maturation in human epithelial HeLa cells treated with interferon-γ.
Yamazaki T; Matsuo J; Nakamura S; Oguri S; Yamaguchi H
J Infect Chemother; 2014 Aug; 20(8):460-4. PubMed ID: 24855914
[TBL] [Abstract][Full Text] [Related]
24. Comparison of gamma interferon-mediated antichlamydial defense mechanisms in human and mouse cells.
Roshick C; Wood H; Caldwell HD; McClarty G
Infect Immun; 2006 Jan; 74(1):225-38. PubMed ID: 16368976
[TBL] [Abstract][Full Text] [Related]
25. Implications for persistent chlamydial infections of phagocyte-microorganism interplay.
Sarov I; Geron E; Shemer-Avni Y; Manor E; Zvillich M; Wallach D; Schmitz E; Holtman H
Eur J Clin Microbiol Infect Dis; 1991 Feb; 10(2):119-23. PubMed ID: 1907541
[TBL] [Abstract][Full Text] [Related]
26. [Study on the inhibitory effects of minocycline on genital Chlamydia trachomatis in McCoy cell culture].
Hosomura Y
Kansenshogaku Zasshi; 1990 Mar; 64(3):310-20. PubMed ID: 2358712
[TBL] [Abstract][Full Text] [Related]
27. Potentiating effect of murine interferon-gamma-containing lymphokine preparations on the antiviral and antiproliferative effects of murine interferon-alpha/beta: identification of the potentiation factor as murine interferon-gamma itself.
Fleischmann WR; Fleischmann CM
Antiviral Res; 1984 Aug; 4(4):221-8. PubMed ID: 6091541
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Chlamydia trachomatis replication in HEp-2 cells by human monocyte-derived macrophages.
Manor E; Sarov I
Infect Immun; 1988 Dec; 56(12):3280-4. PubMed ID: 3182081
[TBL] [Abstract][Full Text] [Related]
29. Three temporal classes of gene expression during the Chlamydia trachomatis developmental cycle.
Shaw EI; Dooley CA; Fischer ER; Scidmore MA; Fields KA; Hackstadt T
Mol Microbiol; 2000 Aug; 37(4):913-25. PubMed ID: 10972811
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of gamma interferon on Chlamydia trachomatis growth in polarized and nonpolarized human epithelial cells in culture.
Kane CD; Byrne GI
Infect Immun; 1998 May; 66(5):2349-51. PubMed ID: 9573129
[TBL] [Abstract][Full Text] [Related]
31. Low-nutrient induction of abnormal chlamydial development: a novel component of chlamydial pathogenesis?
Coles AM; Reynolds DJ; Harper A; Devitt A; Pearce JH
FEMS Microbiol Lett; 1993 Jan; 106(2):193-200. PubMed ID: 8454184
[TBL] [Abstract][Full Text] [Related]
32. Ultrastructural analysis of the effect of trimethoprim and sulphamethoxazole on the development of Chlamydia trachomatis in cell culture.
Hammerschlag MR; Vuletin JC
J Antimicrob Chemother; 1985 Feb; 15(2):209-17. PubMed ID: 3980310
[TBL] [Abstract][Full Text] [Related]
33. Azithromycin-induced block of elementary body formation in Chlamydia trachomatis.
Engel JN
Antimicrob Agents Chemother; 1992 Oct; 36(10):2304-9. PubMed ID: 1280057
[TBL] [Abstract][Full Text] [Related]
34. Less inhibition of interferon-gamma to organism growth in host cells may contribute to the high susceptibility of C3H mice to Chlamydia trachomatis lung infection.
Qiu H; Yang J; Bai H; Fan Y; Wang S; Han X; Chen L; Yang X
Immunology; 2004 Apr; 111(4):453-61. PubMed ID: 15056383
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of Chlamydia trachomatis growth by recombinant tumor necrosis factor.
Shemer-Avni Y; Wallach D; Sarov I
Infect Immun; 1988 Sep; 56(9):2503-6. PubMed ID: 3410548
[TBL] [Abstract][Full Text] [Related]
36. Activation of mouse peritoneal macrophages in vitro or in vivo by recombinant murine gamma interferon inhibits the growth of Chlamydia trachomatis serovar L1.
Zhong GM; de la Maza LM
Infect Immun; 1988 Dec; 56(12):3322-5. PubMed ID: 3141289
[TBL] [Abstract][Full Text] [Related]
37. Cytochemical localization of glycogen in Chlamydia trachomatis inclusions.
Chiappino ML; Dawson C; Schachter J; Nichols BA
J Bacteriol; 1995 Sep; 177(18):5358-63. PubMed ID: 7545158
[TBL] [Abstract][Full Text] [Related]
38. Immunoelectron-microscopic quantitation of differential levels of chlamydial proteins in a cell culture model of persistent Chlamydia trachomatis infection.
Beatty WL; Morrison RP; Byrne GI
Infect Immun; 1994 Sep; 62(9):4059-62. PubMed ID: 7914884
[TBL] [Abstract][Full Text] [Related]
39. Interferon-gamma synergizes with tumor necrosis factor and with interleukin 1 and requires the presence of both monokines to induce antitumor cytotoxic activity in macrophages.
Chen L; Suzuki Y; Wheelock EF
J Immunol; 1987 Dec; 139(12):4096-101. PubMed ID: 3121728
[TBL] [Abstract][Full Text] [Related]
40. Characterization of gamma interferon-mediated cytotoxicity to chlamydia-infected fibroblasts.
Byrne GI; Schobert CS; Williams DM; Krueger DA
Infect Immun; 1989 Mar; 57(3):870-4. PubMed ID: 2492975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
